10 20 30 40 50 60 70 80 1MD3 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSFERASE 06-AUG-02 1MD3
TITLE A FOLDING MUTANT OF HUMAN CLASS PI GLUTATHIONE TRANSFERASE, TITLE 2 CREATED BY MUTATING GLYCINE 146 OF THE WILD-TYPE PROTEIN TITLE 3 TO ALANINE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PI GLUTATHIONE TRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HGSTP1-1, GLUTATHIONE S-TRANSFERASE P; COMPND 5 EC: 2.5.1.18; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: XL_1 BLUE; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PKHP1
KEYWDS GST, NUCLEATION MECHANISM, CONSERVED FOLDING MODULE, KEYWDS 2 TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR G.K.-W.KONG,B.DRAGANI,A.ACETO,R.COCCO,B.MANNERVIK, AUTHOR 2 G.STENBERG,W.J.MCKINSTRY,G.POLEKHINA,M.W.PARKER
REVDAT 3 24-FEB-09 1MD3 1 VERSN REVDAT 2 22-JUL-03 1MD3 1 JRNL REVDAT 1 21-AUG-02 1MD3 0
JRNL AUTH G.K.-W.KONG,G.POLEKHINA,W.J.MCKINSTRY,M.W.PARKER, JRNL AUTH 2 B.DRAGANI,A.ACETO,D.PALUDI,D.R.PRINCIPE, JRNL AUTH 3 B.MANNERVIK,G.STENBERG JRNL TITL CONTRIBUTION OF GLYCINE 146 TO A CONSERVED FOLDING JRNL TITL 2 MODULE AFFECTING STABILITY AND REFOLDING OF HUMAN JRNL TITL 3 GLUTATHIONE TRANSFERASE P1-1 JRNL REF J.BIOL.CHEM. V. 278 1291 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12414796 JRNL DOI 10.1074/JBC.M209581200
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.03 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.03 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1569797.240 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 29159 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1454 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.03 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.10 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4338 REMARK 3 BIN R VALUE (WORKING SET) : 0.2776 REMARK 3 BIN FREE R VALUE : 0.3012 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 136 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3264 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 423 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.61000 REMARK 3 B22 (A**2) : -4.34000 REMARK 3 B33 (A**2) : -2.27000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.90000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.19 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 BOND ANGLES (DEGREES) : 1.60 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.99 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.170 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.680 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.930 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.610 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 53.52 REMARK 3 REMARK 3 NCS MODEL : CONSTR REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : MES.PARAM REMARK 3 PARAMETER FILE 4 : GSH.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : MES.TOP REMARK 3 TOPOLOGY FILE 4 : GSH.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1MD3 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-AUG-02. REMARK 100 THE RCSB ID CODE IS RCSB016826.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54179 REMARK 200 MONOCHROMATOR : NICKEL REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29161 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.030 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.03 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.27300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 10GS REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.33 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: MES, PEG 8000, CALCIUM CHLORIDE, REMARK 280 DTT(DITHIOTHREITOL), GLUTATHIONE(REDUCED), PH 5.6, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 295K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 39.21500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.86000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 39.21500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 44.86000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A3099 LIES ON A SPECIAL POSITION.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 1 REMARK 465 PRO B 1
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 74 NE - CZ - NH1 ANGL. DEV. = 3.4 DEGREES REMARK 500 ARG A 74 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 ARG B 74 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 74 NE - CZ - NH2 ANGL. DEV. = -4.8 DEGREES REMARK 500 ARG B 182 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG B 182 NE - CZ - NH2 ANGL. DEV. = -3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 64 108.97 85.19 REMARK 500 LEU A 78 52.34 -118.72 REMARK 500 TYR A 79 37.25 -141.57 REMARK 500 ASN A 110 65.87 -175.80 REMARK 500 THR A 141 -102.84 -117.47 REMARK 500 ALA A 145 -141.64 55.94 REMARK 500 TYR A 198 -62.18 -98.51 REMARK 500 GLN B 64 109.14 84.78 REMARK 500 ASN B 110 64.01 -176.31 REMARK 500 THR B 141 -93.51 -116.59 REMARK 500 ALA B 145 -143.95 55.65 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 1001 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES B 2001 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH A 3001 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GSH B 4001
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1MD4 RELATED DB: PDB REMARK 900 1MD4 CONTAINS THE SAME PROTEIN, G146V MUTANT
DBREF 1MD3 A 1 209 UNP P09211 GSTP1_HUMAN 1 209 DBREF 1MD3 B 1 209 UNP P09211 GSTP1_HUMAN 1 209
SEQADV 1MD3 ALA A 145 UNP P09211 GLY 145 ENGINEERED SEQADV 1MD3 ALA B 145 UNP P09211 GLY 145 ENGINEERED
SEQRES 1 A 209 PRO PRO TYR THR VAL VAL TYR PHE PRO VAL ARG GLY ARG SEQRES 2 A 209 CYS ALA ALA LEU ARG MET LEU LEU ALA ASP GLN GLY GLN SEQRES 3 A 209 SER TRP LYS GLU GLU VAL VAL THR VAL GLU THR TRP GLN SEQRES 4 A 209 GLU GLY SER LEU LYS ALA SER CYS LEU TYR GLY GLN LEU SEQRES 5 A 209 PRO LYS PHE GLN ASP GLY ASP LEU THR LEU TYR GLN SER SEQRES 6 A 209 ASN THR ILE LEU ARG HIS LEU GLY ARG THR LEU GLY LEU SEQRES 7 A 209 TYR GLY LYS ASP GLN GLN GLU ALA ALA LEU VAL ASP MET SEQRES 8 A 209 VAL ASN ASP GLY VAL GLU ASP LEU ARG CYS LYS TYR ILE SEQRES 9 A 209 SER LEU ILE TYR THR ASN TYR GLU ALA GLY LYS ASP ASP SEQRES 10 A 209 TYR VAL LYS ALA LEU PRO GLY GLN LEU LYS PRO PHE GLU SEQRES 11 A 209 THR LEU LEU SER GLN ASN GLN GLY GLY LYS THR PHE ILE SEQRES 12 A 209 VAL ALA ASP GLN ILE SER PHE ALA ASP TYR ASN LEU LEU SEQRES 13 A 209 ASP LEU LEU LEU ILE HIS GLU VAL LEU ALA PRO GLY CYS SEQRES 14 A 209 LEU ASP ALA PHE PRO LEU LEU SER ALA TYR VAL GLY ARG SEQRES 15 A 209 LEU SER ALA ARG PRO LYS LEU LYS ALA PHE LEU ALA SER SEQRES 16 A 209 PRO GLU TYR VAL ASN LEU PRO ILE ASN GLY ASN GLY LYS SEQRES 17 A 209 GLN SEQRES 1 B 209 PRO PRO TYR THR VAL VAL TYR PHE PRO VAL ARG GLY ARG SEQRES 2 B 209 CYS ALA ALA LEU ARG MET LEU LEU ALA ASP GLN GLY GLN SEQRES 3 B 209 SER TRP LYS GLU GLU VAL VAL THR VAL GLU THR TRP GLN SEQRES 4 B 209 GLU GLY SER LEU LYS ALA SER CYS LEU TYR GLY GLN LEU SEQRES 5 B 209 PRO LYS PHE GLN ASP GLY ASP LEU THR LEU TYR GLN SER SEQRES 6 B 209 ASN THR ILE LEU ARG HIS LEU GLY ARG THR LEU GLY LEU SEQRES 7 B 209 TYR GLY LYS ASP GLN GLN GLU ALA ALA LEU VAL ASP MET SEQRES 8 B 209 VAL ASN ASP GLY VAL GLU ASP LEU ARG CYS LYS TYR ILE SEQRES 9 B 209 SER LEU ILE TYR THR ASN TYR GLU ALA GLY LYS ASP ASP SEQRES 10 B 209 TYR VAL LYS ALA LEU PRO GLY GLN LEU LYS PRO PHE GLU SEQRES 11 B 209 THR LEU LEU SER GLN ASN GLN GLY GLY LYS THR PHE ILE SEQRES 12 B 209 VAL ALA ASP GLN ILE SER PHE ALA ASP TYR ASN LEU LEU SEQRES 13 B 209 ASP LEU LEU LEU ILE HIS GLU VAL LEU ALA PRO GLY CYS SEQRES 14 B 209 LEU ASP ALA PHE PRO LEU LEU SER ALA TYR VAL GLY ARG SEQRES 15 B 209 LEU SER ALA ARG PRO LYS LEU LYS ALA PHE LEU ALA SER SEQRES 16 B 209 PRO GLU TYR VAL ASN LEU PRO ILE ASN GLY ASN GLY LYS SEQRES 17 B 209 GLN
HET MES A1001 12 HET MES B2001 12 HET GSH A3001 20 HET GSH B4001 20
HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETNAM GSH GLUTATHIONE
FORMUL 3 MES 2(C6 H13 N O4 S) FORMUL 5 GSH 2(C10 H17 N3 O6 S) FORMUL 7 HOH *423(H2 O)
HELIX 1 1 ARG A 11 ARG A 13 5 3 HELIX 2 2 CYS A 14 GLN A 24 1 11 HELIX 3 3 THR A 34 GLY A 41 1 8 HELIX 4 4 GLY A 41 CYS A 47 1 7 HELIX 5 5 GLN A 64 LEU A 76 1 13 HELIX 6 6 ASP A 82 ASN A 110 1 29 HELIX 7 7 ASN A 110 GLN A 135 1 26 HELIX 8 8 ASN A 136 LYS A 140 5 5 HELIX 9 9 SER A 149 ALA A 166 1 18 HELIX 10 10 PHE A 173 ALA A 185 1 13 HELIX 11 11 ARG A 186 SER A 195 1 10 HELIX 12 12 SER A 195 ASN A 200 1 6 HELIX 13 13 ARG B 11 ARG B 13 5 3 HELIX 14 14 CYS B 14 GLN B 24 1 11 HELIX 15 15 THR B 34 GLU B 40 1 7 HELIX 16 16 GLY B 41 CYS B 47 1 7 HELIX 17 17 GLN B 64 GLY B 77 1 14 HELIX 18 18 ASP B 82 ASN B 110 1 29 HELIX 19 19 ASN B 110 GLN B 135 1 26 HELIX 20 20 ASN B 136 LYS B 140 5 5 HELIX 21 21 SER B 149 ALA B 166 1 18 HELIX 22 22 PHE B 173 ARG B 186 1 14 HELIX 23 23 ARG B 186 SER B 195 1 10 HELIX 24 24 SER B 195 ASN B 200 1 6
SHEET 1 A 4 TRP A 28 VAL A 32 0 SHEET 2 A 4 TYR A 3 TYR A 7 1 N VAL A 5 O GLU A 31 SHEET 3 A 4 LYS A 54 ASP A 57 -1 O LYS A 54 N VAL A 6 SHEET 4 A 4 LEU A 60 TYR A 63 -1 O LEU A 62 N PHE A 55 SHEET 1 B 4 TRP B 28 VAL B 32 0 SHEET 2 B 4 TYR B 3 TYR B 7 1 N VAL B 5 O LYS B 29 SHEET 3 B 4 LYS B 54 ASP B 57 -1 O LYS B 54 N VAL B 6 SHEET 4 B 4 LEU B 60 TYR B 63 -1 O LEU B 62 N PHE B 55
CISPEP 1 LEU A 52 PRO A 53 0 0.90 CISPEP 2 LEU B 52 PRO B 53 0 0.45
SITE 1 AC1 7 ALA A 22 TRP A 28 GLU A 30 GLU A 197 SITE 2 AC1 7 HOH A3106 HOH A3175 ASP B 171 SITE 1 AC2 5 HOH A3085 TRP B 28 PHE B 192 GLU B 197 SITE 2 AC2 5 HOH B4184 SITE 1 AC3 15 TYR A 7 PHE A 8 ARG A 13 TRP A 38 SITE 2 AC3 15 LYS A 44 GLN A 51 LEU A 52 PRO A 53 SITE 3 AC3 15 GLN A 64 SER A 65 HOH A3016 HOH A3026 SITE 4 AC3 15 HOH A3158 HOH A3212 ASP B 98 SITE 1 AC4 12 ASP A 98 TYR B 7 PHE B 8 ARG B 13 SITE 2 AC4 12 TRP B 38 LYS B 44 GLN B 51 LEU B 52 SITE 3 AC4 12 GLN B 64 SER B 65 HOH B4040 HOH B4068
CRYST1 78.430 89.720 69.000 90.00 98.39 90.00 C 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.012750 0.000000 0.001881 0.00000
SCALE2 0.000000 0.011146 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014650 0.00000